Imedex E-learning (audio)

Chronic Myeloid Leukemia: Keeping Up with Evolving Treatment Landscapes in Clinical Pathways - Gabriela Hobbs, MD

Informações:

Sinopsis

This webcast examines the most recent evidence-based guidelines to optimize individualized tyrosine kinase inhibitor (TKI) selection for CML patients based on disease phase, treatment history, genetic mutation profile, and comorbidities.